NEW YORK, Nov. 22 (GenomeWeb News) - Shares in Bruker BioSciences were up 8.4 percent at $4.27 in mid-afternoon trading after CEO Frank Laukien spent five days buying $781,000 worth of Bruker stock.

 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.

In Science this week: in vitro generation of human reproductive cells, and more.